INDO-GLOBAL ENT. | FORTIS HEALTHCARE | INDO-GLOBAL ENT./ FORTIS HEALTHCARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -31.9 | 58.4 | - | View Chart |
P/BV | x | 1.4 | 4.6 | 31.2% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
INDO-GLOBAL ENT. FORTIS HEALTHCARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDO-GLOBAL ENT. Mar-20 |
FORTIS HEALTHCARE Mar-23 |
INDO-GLOBAL ENT./ FORTIS HEALTHCARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 20 | 325 | 6.3% | |
Low | Rs | 20 | 220 | 9.3% | |
Sales per share (Unadj.) | Rs | 0 | 83.4 | 0.0% | |
Earnings per share (Unadj.) | Rs | -0.7 | 8.4 | -7.8% | |
Cash flow per share (Unadj.) | Rs | -0.7 | 12.6 | -5.2% | |
Dividends per share (Unadj.) | Rs | 0 | 1.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.4 | 0.0% | |
Book value per share (Unadj.) | Rs | 11.1 | 95.9 | 11.6% | |
Shares outstanding (eoy) | m | 6.37 | 754.96 | 0.8% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 3.3 | - | |
Avg P/E ratio | x | -31.1 | 32.5 | -95.8% | |
P/CF ratio (eoy) | x | -31.1 | 21.7 | -143.6% | |
Price / Book Value ratio | x | 1.8 | 2.8 | 64.7% | |
Dividend payout | % | 0 | 11.9 | -0.0% | |
Avg Mkt Cap | Rs m | 130 | 205,575 | 0.1% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1 | 10,469 | 0.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 62,976 | 0.0% | |
Other income | Rs m | 0 | 617 | 0.0% | |
Total revenues | Rs m | 0 | 63,593 | 0.0% | |
Gross profit | Rs m | -1 | 11,968 | -0.0% | |
Depreciation | Rs m | 0 | 3,157 | 0.0% | |
Interest | Rs m | 1 | 1,291 | 0.1% | |
Profit before tax | Rs m | -2 | 8,137 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 2 | 1,807 | 0.1% | |
Profit after tax | Rs m | -4 | 6,330 | -0.1% | |
Gross profit margin | % | 0 | 19.0 | - | |
Effective tax rate | % | -93.4 | 22.2 | -420.7% | |
Net profit margin | % | 0 | 10.1 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 11,503 | 0.0% | |
Current liabilities | Rs m | 7 | 13,136 | 0.1% | |
Net working cap to sales | % | 0 | -2.6 | - | |
Current ratio | x | 0 | 0.9 | 0.7% | |
Inventory Days | Days | 0 | 60 | - | |
Debtors Days | Days | 0 | 337 | - | |
Net fixed assets | Rs m | 80 | 106,830 | 0.1% | |
Share capital | Rs m | 64 | 7,550 | 0.8% | |
"Free" reserves | Rs m | 7 | 64,856 | 0.0% | |
Net worth | Rs m | 71 | 72,405 | 0.1% | |
Long term debt | Rs m | 2 | 5,722 | 0.0% | |
Total assets | Rs m | 80 | 120,893 | 0.1% | |
Interest coverage | x | -2.1 | 7.3 | -29.0% | |
Debt to equity ratio | x | 0 | 0.1 | 42.8% | |
Sales to assets ratio | x | 0 | 0.5 | 0.0% | |
Return on assets | % | -4.4 | 6.3 | -69.1% | |
Return on equity | % | -5.9 | 8.7 | -67.6% | |
Return on capital | % | -2.0 | 12.1 | -16.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 108 | 0.0% | |
Fx outflow | Rs m | 0 | 23 | 0.0% | |
Net fx | Rs m | 0 | 85 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | -1 | 8,222 | -0.0% | |
From Investments | Rs m | NA | -3,737 | -0.0% | |
From Financial Activity | Rs m | 1 | -4,712 | -0.0% | |
Net Cashflow | Rs m | 0 | -215 | -0.0% |
Indian Promoters | % | 2.8 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 31.2 | - | |
Indian inst/Mut Fund | % | 0.0 | 54.4 | - | |
FIIs | % | 0.0 | 23.2 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 97.2 | 68.8 | 141.2% | |
Shareholders | 543 | 157,165 | 0.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDO-GLOBAL ENT. With: APOLLO HOSPITALS DR. LAL PATHLABS KIMS METROPOLIS HEALTHCARE NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | INDO-GLOBAL ENT. | FORTIS HEALTHCARE |
---|---|---|
1-Day | -4.76% | 0.17% |
1-Month | 6.24% | 8.10% |
1-Year | -13.28% | 71.50% |
3-Year CAGR | -7.78% | 29.38% |
5-Year CAGR | -4.74% | 26.16% |
* Compound Annual Growth Rate
Here are more details on the INDO-GLOBAL ENT. share price and the FORTIS HEALTHCARE share price.
Moving on to shareholding structures...
The promoters of INDO-GLOBAL ENT. hold a 2.8% stake in the company. In case of FORTIS HEALTHCARE the stake stands at 31.2%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of INDO-GLOBAL ENT. and the shareholding pattern of FORTIS HEALTHCARE.
Finally, a word on dividends...
In the most recent financial year, INDO-GLOBAL ENT. paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
FORTIS HEALTHCARE paid Rs 1.0, and its dividend payout ratio stood at 11.9%.
You may visit here to review the dividend history of INDO-GLOBAL ENT., and the dividend history of FORTIS HEALTHCARE.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.